Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bern
Clinical trial register · Switzerland

Clinical Trials in Bern, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Switzerland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2249 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2249
Studies in scope
all four open statuses
1364
Recruiting now
open to new participants
528
Lead sponsors
across recruiting studies
Top sites
Zurich 739 Bern 722 Basel 636 Geneva 406 Lausanne 394
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Insel Gruppe AG, University Hospital Bern162 University of Bern50 University Hospital, Basel, Switzerland31 Novartis Pharmaceuticals22 AbbVie15 Hoffmann-La Roche15 Swiss Cancer Institute14 Merck Sharp & Dohme LLC12 Takeda11 Janssen Research & Development, LLC10 AstraZeneca9 Amgen9 University of Zurich8 European Organisation for Research and Treatment of Cancer - EORTC8 Incyte Corporation7 ETOP IBCSG Partners Foundation7 Pfizer7 Sanofi7 Edwards Lifesciences6 Bristol-Myers Squibb6 Novo Nordisk A/S6 Stichting Hemato-Oncologie voor Volwassenen Nederland6 Abbott Medical Devices6 Medtronic Cardiovascular4 Alexion Pharmaceuticals, Inc.4 Jasper Gerritsen4 Gilead Sciences4 Alnylam Pharmaceuticals4 Medtronic4 Boston Scientific Corporation4 University Hospital, Geneva4 Akero Therapeutics, Inc3 Fondazione Epatocentro Ticino3 Medtronic Cardiac Ablation Solutions3 Bern University of Applied Sciences3 International Extranodal Lymphoma Study Group (IELSG)3 IntraBio Inc3 OncoVerity, Inc.3 Vertex Pharmaceuticals Incorporated3 University Children's Hospital Basel3 Azafaros B.V.3 Daiichi Sankyo3 Boehringer Ingelheim3 ETH Zurich2 Zimmer Biomet2 Eli Lilly and Company2 Ipsen2 Medical University Innsbruck2 Celgene2 Erasmus Medical Center2 Swiss GO Trial Group2 Eisai Inc.2 Implantica CE Reflux Ltd.2 Philogen S.p.A.2 M.A. Med Alliance S.A.2 Merz Therapeutics GmbH2 Penumbra Inc.2 Berner Augenklinik2 Medtronic Cardiac Surgery2 University Medical Center Groningen2 University Hospital Muenster2 University of Birmingham2 Centre Hospitalier Universitaire Vaudois2 Olgun Elicin2 Kantonsspital Winterthur KSW2 CSL Behring2 Region Skane2 Medacta International SA2 Lindenhofgruppe AG2 DCB Research AG2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Morten H. Bestle1 Roza Umarova1 Vrije Universiteit Brussel1 Corcym S.r.l1 Inari Medical1 National Institute of Oncology, Hungary1 Swiss Dermatology Network for Targeted Therapies1 Biosense Webster, Inc.1 University Children's Hospital, Zurich1 Nantes University Hospital1 FCRE (Foundation for Cardiovascular Research and Education)1 Benoit Guery1 PedNet Haemophilia Research Foundation1 Felix Mueller1 Swedish Orphan Biovitrum1 Antonio Leidi1 Exelixis1 Viatris Innovation GmbH1 PENTA Foundation1 Helsinki University Central Hospital1 T3 Pharmaceuticals AG1 Alentis Therapeutics AG1 Orchestra BioMed, Inc1 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 X4 Pharmaceuticals1 Uptake Medical Technology, Inc.1 Genzyme, a Sanofi Company1 Kite, A Gilead Company1 Universitätsklinikum Hamburg-Eppendorf1 Sonja Stieb, MD1 Kyowa Kirin Pharmaceutical Development Ltd1 Occlutech International AB1 GlaxoSmithKline1 LMU Klinikum1 University Hospital, Ghent1 ECRI bv1 Seagen, a wholly owned subsidiary of Pfizer1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Pierre Fabre Pharma GmbH1 Abivax S.A.1 Medtronic Neurovascular Clinical Affairs1 argenx1 Bayer1 GWT-TUD GmbH1 ONL Therapeutics1 Jules Bordet Institute1 Deciphera Pharmaceuticals, LLC1 Susanne Rogers1 Swiss Society of Dermatology and Venereology1 Andrea Goldmann1 European Institute of Oncology1 Medical Research Council1 Larissa University Hospital1 Sobet AG1 BeOne Medicines1 Pierre Mégevand1 ITM Solucin GmbH1 Stemline Therapeutics, Inc.1 University of Fribourg1 Philipp Schuetz1 Hannover Medical School1 EMD Serono Research & Development Institute, Inc.1 Norwegian University of Science and Technology1 Michael von Wolff1 Drahomir Aujesky1 Christian Haslinger1 Madrigal Pharmaceuticals, Inc.1 Centro per la Lotta Contro l'Infarto - Fondazione Onlus1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Sitala Bio LTD1 Biogen1 The Leeds Teaching Hospitals NHS Trust1 EyeBiotech Ltd.1 European Myeloma Network B.V.1 W.L.Gore & Associates1 Stryker Trauma and Extremities1 Sequana Medical N.V.1 University of Kiel1 ZIWIG1 Ente Ospedaliero Cantonale, Bellinzona1 Thurgau Breast Center1 University of Lausanne1 Regeneron Pharmaceuticals1 Mitera Hospital1 V-Wave Ltd1 Carag AG1 Martin Schrappe1 Thomas Pilgrim1 Ottawa Heart Institute Research Corporation1 Uppsala University1 Western Sydney Local Health District1 Institut Curie1 Stichting European Myeloma Network1 Unity Health Toronto1 University of Cambridge1 Alliance for Clinical Trials in Oncology1 Tesaro, Inc.1 Telethon Kids Institute1 Calmy Alexandra1 Lia Bally1 Vesalio1 Christoph Berger1 Adrian Guggisberg1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Spyre Therapeutics, Inc.1 Biotronik AG1 Newcastle University1 Cardionovum GmbH1 Marc Blondon1 Technische Universität Dresden1 Gustave Roussy, Cancer Campus, Grand Paris1 German CLL Study Group1 Baris Gencer1 Astellas Pharma Global Development, Inc.1 Biotronik SE & Co. KG1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 MED-EL Elektromedizinische Geräte GmbH1 Onovis Augenpraxis1 Mustafa Kemal University1 Matthias Wilhelm, MD1 Thomas Riva1 Sumitomo Pharma America, Inc.1 King's College Hospital NHS Trust1 University of Oxford1 North Eastern German Society of Gynaecological Oncology1 Galderma R&D1 hemotune AG1 UCB Biopharma SRL1 Christoph Nissen1 VU University of Amsterdam1 Aarhus University Hospital1 CarThera1 Sigmund Freud PrivatUniversitat1 University of Padova1 Fondazione Don Carlo Gnocchi ETS1 Thomas Jefferson University1 Heinrich-Heine University, Duesseldorf1 Alain Kaelin1 machineMD AG1 Janssen-Cilag A.G., Switzerland1 The Mediterranean Institute for Transplantation and Advanced Specialized Therapies1 University of Basel1 Cleveland Clinic London1 Hospital Centre Biel/Bienne1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Steffen Paschen1 Octapharma1 Geron Corporation1 Rede Optimus Hospitalar SA1 Immunophotonics, Inc.1 Heidelberg University1 Raban Jeger1 Genentech, Inc.1 Australian and New Zealand Intensive Care Research Centre1 Abiomed Inc.1 Copenhagen University Hospital, Rigshospitalet1 Stryker Neurovascular1 Prof. Dr. Jörg Leuppi1 Nurix Therapeutics, Inc.1 ADARx Pharmaceuticals, Inc.1 Ivy Brain Tumor Center1 Merz Pharmaceuticals GmbH1 Fabiën Belle1 Berner Reha Zentrum AG1
Site location
Zurich739 Bern722 Basel636 Geneva406 Lausanne394 Sankt Gallen272 Lucerne152 Bellinzona148 Aarau136 Lugano131 Chur99 Baden81 Winterthur81 Fribourg72 Liestal35 Olten32 Sion24 Frauenfeld22 Thun19 Münsterlingen15 Nottwil15 Biel14 Neuchâtel13 Solothurn12 Meyrin12 Villars-sur-Glâne11 Basel Town8 Binningen8 Schlieren7 Rheinfelden6 Delémont5 Yverdon-les-Bains5 Buochs5 Locarno5 Bülach5 Chêne-Bougeries5 Valens5 Biel/Bienne5 Zollikerberg5 La Chaux-de-Fonds5 Wetzikon4 Genolier4 Viganello4 Zollikon4 Mendrisio4 Lachen3 Multiple Locations3 Davos3 Rennaz3 Many Locations3 Morges3 Uster3 Männedorf3 Gümligen3 Brig3 Horgen3 Manno3 Rorschach2 Langenthal2 Uznach2 Saint Ursen2 Muttenz2 Wabern2 Reinach2 Bad Zurzach2 Weinfelden2 Heiligenschwendi2 Arzo2 Zürich Flughafen2 Barmelweid2 Vitznau2 Allschwil2 Burgdorf2 Bruderholz2 Zuerich2 Carouge2 Kreuzlingen1 Onex1 Egerkingen1 Oberrieden1 Konolfingen1 Nyon1 Heerbrugg1 Pfäfers Dorf1 Sargans1 Wattwil1 Wil1 Surich1 Weggis1 Rapperswil1 Herzogenbuchsee1 Willisau1 Petersgraben1 Tellstrasse1 Windisch1 Bulle1 Süs1 Walzenenhausen1 Plan-les-Ouates1 Vernier1 Palézieux1 Sierre1 Grand-Lancy1 Lonay1 Gravesano1 Herisau1 Zug1 Zürich-Flughafen1 Cottens1 Rolle1 Granges-Paccot1 Zürich (de)1 Crans-Montana1 Kilchberg1 Zofingen1 Paradiso1 Sursee1 Lazern 161 Collonge-Bellerive1 Binnigen1 Villars-sûr-glâne1 Muri bei Bern1 Stäfa1 Orsières1 Zurich-Flughafen1 Cama1 Lostallo1 Villigen1 Visp1 Meiringen1 Bellikon1 Zihlschlacht1 Münchenbuchsee1 Sankt Urban1 Brissago1 Schaffhausen1 Morbio Inferiore1 Sonvico1 Murten/Morat1 Arlesheim1 Aarberg1 Schwendi1 Obbürgen1 Interlaken1 Sullens1 Écublens1 Oberwil1 Rothrist1 La ChauxdeFonds1 Meyriez1 Vevey1
All 151 locations
Target enrolment
to

Trials with a site in Bern

722 of 2249 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Switzerland
Start
Not yet open
University of Bern
Not applicable
50
Bern
2027-12-01
Not yet open
University of Bern
Not applicable
50
Bern
2027-12-01
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Basel, Bern, Lucerne, Sankt Gallen, Zurich
2027-11-23
Not yet open
Insel Gruppe AG, University Hospital Bern
Phase 4
30
Bern
2027-06-01
Not yet open
Lattice vs Pentaspline Comparative Evaluation in Persistent AF
NCT07815171Persistent Atrial Fibrillation
Mitera Hospital
Not applicable
250
Bern
2027-03
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Basel, Bern, Zurich
2027-02-03
Not yet open
Insel Gruppe AG, University Hospital Bern
Not applicable
50
Bern
2027-02
Not yet open
Bern University of Applied Sciences
Not applicable
60
Bern
2026-12-01
Not yet open
Hospital Centre Biel/Bienne
Phase 2
28
Bern, Biel
2026-12-01
Not yet open
Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.
NCT07480395Complex Aortic Aneurysms, Thoracoabdominal Aneurysm, Fenestrated Endovascular Aortic Repair, Endovascular Aortic Repair
W.L.Gore & Associates
Observational
400
Basel, Bern
2026-12
Not yet open
Insel Gruppe AG, University Hospital Bern
Not applicable
64
Bern
2026-11-01
Not yet open
Bookbased Emotion and Anxiety Reduction
NCT07812272Pediatric Anesthesia, Pediatric Surgery, Perioperative Care, Perioperative Anxiety
Insel Gruppe AG, University Hospital Bern
Not applicable
50
Bern
2026-11-01
Not yet open
EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
NCT05688241EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland
Phase 1/2
10
Basel, Bern, Geneva, Lausanne, Zurich
2026-11
Not yet open
University of Bern
Observational
70
Bern
2026-11
Not yet open
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Prostatic Neoplasms, Biochemical Recurrence, Oligometastatic Prostate Cancer
DrugEnzalutamide
Ente Ospedaliero Cantonale, Bellinzona
Phase 3
140
Aarau, Bellinzona, Bern, Chur, Münsterlingen, Winterthur, Zurich
2026-11
Not yet open
Insel Gruppe AG, University Hospital Bern
Observational
110
Bern
2026-11
Recruiting
Pediatric Research in the Outpatient Setting CoHort
NCT07911228Parental Stress, Communication Disorder, Childhood, Development and Health
Insel Gruppe AG, University Hospital Bern
Observational
200
Bern
2026-10-26
Recruiting
Swiss Cancer Institute
Phase 2
108
Fribourg, Basel, Bellinzona, Bern, Geneva, Lausanne, Münsterlingen, Sankt Gallen
2026-10-12
Recruiting
Bristol-Myers Squibb
Phase 1/2
84
Bern, Geneva
2026-10-06
Recruiting
University of Bern
Observational
35
Bern
2026-10-01
Not yet open
Insel Gruppe AG, University Hospital Bern
Not applicable
40
Bern
2026-10-01
Not yet open
MED-EL Elektromedizinische Geräte GmbH
Observational
700
Bern
2026-10
Not yet open
Ovate Pontic Versus Essix Provisional After Tooth Extraction and Alveolar Ridge Preservation (Pontic-Essix)
NCT07748871Tooth Loss / Rehabilitation, Tooth Extraction, Alveolar Bone Loss, Alveolar Ridge Augmentation
University of Bern
Not applicable
40
Bern
2026-10
Recruiting
Swiss Cancer Institute
Phase 2
92
Aarau, Basel, Bellinzona, Bern, Chur, Geneva, Lucerne, Sankt Gallen
2026-09-24
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Bellinzona, Bern, Binningen, Lausanne, Zurich
2026-09-11
Recruiting
Incyte Corporation
Phase 3
426
Bern, Sankt Gallen, Tellstrasse, Zurich
2026-09-08
Recruiting
Lindenhofgruppe AG
Not applicable
148
Basel, Bern, Horgen, Zurich
2026-08-25
Recruiting
University Hospital, Basel, Switzerland
Phase 2
9
Bern, Zurich, Lausanne, Basel
2026-08-20
Recruiting
DCB Research AG
Observational
48
Bern
2026-08-19
Active, closed
Pivotal Study of N-acetyl-L-leucine for CACNA1A
NCT07221292CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2, Familial Hemiplegic Migraine-1
DrugN-Acetyl-L-Leucine
IntraBio Inc
Phase 3
60
Bern
2026-08-17
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 4
150
Basel, Bern, Geneva, Lausanne, Zurich
2026-08-05
Recruiting
Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues
NCT07348224Nicotine, Vaping, Synthetic Nicotine, Nicotine Analogues
Insel Gruppe AG, University Hospital Bern
Not applicable
24
Bern
2026-08-05
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
20
Bern
2026-08-01
Not yet open
University Hospital, Basel, Switzerland
Not applicable
270
Basel, Bern, Lausanne, Sankt Gallen, Zurich
2026-08
Recruiting
Night-to-Night Variability of Novel Physiological Parameters in Home Sleep Apnea Testing
NCT07555119Obstructive Apnea, Diagnostic, Sleep Apnea Syndrome (OSAS)
Insel Gruppe AG, University Hospital Bern
Observational
192
Bern
2026-07-24
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Bern
2026-07-16
Not yet open
Insel Gruppe AG, University Hospital Bern
Observational
500
Bern
2026-07-15
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
50
Bern
2026-07-09
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
400
Aarau, Baden, Basel, Bern, Chur, Fribourg, Geneva, Lausanne
2026-07-02
Not yet open
Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)
NCT07478536Prostate Cancer, Active Surveillance for Prostate Cancer
Insel Gruppe AG, University Hospital Bern
Observational
350
Bern
2026-07-01
Not yet open
Insel Gruppe AG, University Hospital Bern
Phase 3
178
Bern
2026-07
By invitation
University of Bern
Observational
50
Bern
2026-06-15
Recruiting
MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
NCT07597122Sepsis and Septic Shock
Insel Gruppe AG, University Hospital Bern
Observational
56
Bern
2026-06-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
170
Aarau, Baden, Basel, Bern, Geneva, Sankt Gallen, Zurich
2026-06-01
Recruiting
Giving Children a Voice in Paediatric Anaesthesia
NCT07524049Perioperative Care, Pediatric Anesthesia, Pain Management, Anxiety
Insel Gruppe AG, University Hospital Bern
Observational
1,040
Aarau, Basel, Bern, Fribourg, Geneva, Lucerne, Bellinzona
2026-05-27
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Basel, Bern, Geneva, Genolier
2026-05-27
Recruiting
BIO|STREAM.CSP Study
NCT07393009Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices
Biotronik SE & Co. KG
Observational
1,000
Bern, Zurich
2026-05-25
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Bern, Saint Ursen, Zurich
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Bern, Saint Ursen
2026-05-22
Recruiting
Takeda
Phase 3
300
Zurich, Chur, Bern
2026-05-21
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 2
36
Bern, Geneva, Lucerne, Zurich
2026-05-20
Recruiting
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2/3
105
Bern
2026-05-19
Recruiting
Ipsen
Phase 3
350
Basel, Bern, Lugano, Zurich
2026-05-14
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Basel, Bern, Geneva, Lausanne, Liestal, Zurich
2026-05-11
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
30
Bern
2026-05-08
Recruiting
AstraZeneca
Phase 3
670
Bern, Geneva, Zurich
2026-05-04
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
40
Bern
2026-05-01
Recruiting
Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation
NCT07597031Chronic Obstructive Pulmonary Disease (COPD), Acute Coronary Syndrome, Fragility Fracture, Minor Stroke
Matthias Wilhelm, MD
Not applicable
240
Bern, Schwendi
2026-05-01
Recruiting
LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery
NCT07168421Perioperative Myocardial Injury, Autonomic Dysfunction, Cardiovascular (CV) Risk, Major Surgery
DrugLandiolol
Insel Gruppe AG, University Hospital Bern
Phase 4
114
Bern
2026-04-24
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Bern, Geneva
2026-04-21
Recruiting
Transcultural Digital Solutions in Phase III Cardiac Rehabilitation
NCT07252856Heart Failure, Myocardial Infarction
Fondazione Don Carlo Gnocchi ETS
Not applicable
306
Bern
2026-04-20
Not yet open
The INSPIRE Study: INvestigation of Swiss Physicians Inner-life, Resilience, and Emotions
NCT06806150Burnout, Professional, Emotional Exhaustion, Emotions, Wellness, Psychological
University of Bern
Not applicable
450
Bern
2026-04-15
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
98
Bern
2026-04-14
Recruiting
A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
NCT07532213Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn Disease
Janssen-Cilag A.G., Switzerland
Observational
50
Bern
2026-04-13
Recruiting
Swiss Cancer Institute
Phase 2
156
Fribourg, Aarau, Baden, Basel, Bellinzona, Bern, Bülach, Chur
2026-04-10
Recruiting
Incyte Corporation
Phase 3
588
Basel, Bern, Geneva, Lausanne, Zurich
2026-04-09
Recruiting
Medtronic Cardiac Ablation Solutions
Not applicable
400
Bern
2026-04-08
Recruiting
Questionnaire on Congenital Cancer Signs Through Self-Assessment
NCT07378423Cancer Predisposition Syndromes, Pediatric Cancer, Childhood Neoplasms, Hereditary Cancer Syndromes
Insel Gruppe AG, University Hospital Bern
Not applicable
205
Bern
2026-04-01
Recruiting
University Hospital, Geneva
Not applicable
150
Geneva, Basel, Bern, Zurich
2026-04-01
Recruiting
Octapharma
Phase 4
28
Bern
2026-04
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
DrugsTiespectus·Eylea·Aflibercept
EyeBiotech Ltd.
Phase 2/3
960
Basel, Bern, Binnigen, Lausanne, Zurich
2026-03-27
Recruiting
Eisai Inc.
Phase 2
64
Bern
2026-03-26
Recruiting
Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation
NCT07201506Ablation of Arrhythmias, Premature Ventricular Contractions, Ventricular Tachycardia, Ventricular Arrhythmia
Insel Gruppe AG, University Hospital Bern
Not applicable
70
Basel, Bern
2026-03-25
Recruiting
University of Bern
Observational
200
Bern
2026-03-22
Recruiting
Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.
NCT07541768Acute Heart Failure (AHF), Fluid Over-load, Congestion, Congestion, Venous
Insel Gruppe AG, University Hospital Bern
Not applicable
23
Bern
2026-03-20
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
3,200
Bern
2026-03-09
Recruiting
Incyte Corporation
Phase 3
700
Bern, Lausanne, Sankt Gallen
2026-03-05
Recruiting
Uppsala University
Observational
2,000
Basel, Bern, Geneva
2026-03-01
Not yet open
Insel Gruppe AG, University Hospital Bern
Not applicable
654
Bern
2026-03-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Basel, Bern, Fribourg, Geneva, Sankt Gallen, Zurich
2026-03-01
Recruiting
Boehringer Ingelheim
Phase 3
286
Bern, Zurich
2026-02-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Bern, Bellinzona, Chur, Geneva
2026-02-16
Recruiting
LITT for Ultra-early GBM Recurrence
NCT07616986Glioblastoma (GBM), Glioblastoma - Category
Insel Gruppe AG, University Hospital Bern
Not applicable
12
Bern
2026-02-06
Recruiting
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
NCT07204990Endotracheal Extubation, Airway Anesthesia, Paediatric
Telethon Kids Institute
Not applicable
1,400
Bern
2026-02-06
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Bern
2026-02-03
By invitation
Neck Rescue Access Comparison
NCT07368179Tracheostomy Complication, Emergency Front of Neck Airway in Children, Anesthesia
Insel Gruppe AG, University Hospital Bern
Not applicable
30
Bern
2026-02-02
By invitation
University of Bern
Not applicable
250
Bern
2026-02-02
Active, closed
Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity
NCT07649759Obesity & Overweight, Emotional Eating Behaviour, Mindful Eating Intervention
Bern University of Applied Sciences
Not applicable
40
Bern
2026-02-01
Not yet open
University of Bern
Not applicable
136
Bern
2026-02-01
Active, closed
Insel Gruppe AG, University Hospital Bern
Observational
40
Bern
2026-01-31
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
DrugTAK-861
Takeda
Phase 3
98
Barmelweid, Bern
2026-01-29
Recruiting
LSD Treatment for Persons With Alcohol Use Disorder
NCT05474989Alcohol Use Disorder (AUD)
Felix Mueller
Phase 2
128
Basel, Bern
2026-01-27
Active, closed
CSL Behring
Phase 2
84
Bern, Lausanne, Lugano
2026-01-22
Recruiting
Sanofi
Phase 3
751
Basel, Bern
2026-01-22
Recruiting
Sanofi
Phase 3
751
Bern
2026-01-16
Recruiting
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
NCT07058805Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Olgun Elicin
Phase 2
50
Basel, Bern, Zurich
2026-01-15
Recruiting
No More Sleepless Nights in Perimenopause
NCT06497894Insomnia, Menopause
Insel Gruppe AG, University Hospital Bern
Phase 4
54
Bern
2026-01-01
Recruiting
Determining the Clinical Impact and Prevalence of Hemorrhagic Subtypes in Perimesencephalic Subarachnoid Hemorrhage
NCT07923084Subarachnoid Hemorrhage, Spontaneous, Subarachnoid Hemorrhage, Aneurysmal, Perimesencephalic Subarachnoid Hemorrhage, Basilar Artery Perforator Aneurysm
Insel Gruppe AG, University Hospital Bern
Observational
264
Bern
2026-01-01
Recruiting
University Hospital, Basel, Switzerland
Not applicable
1,060
Aarau, Baden, Basel, Bern, Bülach, Chêne-Bougeries, Chur, Frauenfeld
2026-01-01
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Baden, Bern, Geneva
2026-01-01
Recruiting
Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
NCT07299994Stroke, Thrombolysis, DAPT(Dual Antiplatelet Therapy), SAPT(Single Antiplatelet Therapy)
Sigmund Freud PrivatUniversitat
Observational
462
Bern
2026-01-01
Active, closed
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097Intermediate-risk Prostate Cancer, High-risk Prostate Cancer
Heinrich-Heine University, Duesseldorf
Observational
600
Bern
2026-01-01
Recruiting
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
NCT07276282Coronary Artery Disease, Acute Myocardial Infarction (AMI), Coronary Atherosclerosis of Native Coronary Artery
DrugZiltivekimab
ECRI bv
Phase 3
332
Bern
2025-12-19
Active, closed
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Bern
2025-12-19
Recruiting
Novo Nordisk A/S
Phase 3
332
Basel, Bern, Geneva, Lucerne
2025-12-18
Recruiting
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
NCT07143539Venous Thromboembolism (VTE), Exercise Therapy, Quality of Life (QOL), Anxiety Depression
Insel Gruppe AG, University Hospital Bern
Not applicable
160
Aarau, Baden, Bern, Geneva, Lausanne, Zurich
2025-12-17
Active, closed
WATCHMAN FLX Pro European Registry
NCT07262255Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure
Boston Scientific Corporation
Observational
189
Basel, Bern
2025-12-17
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
NCT07309497Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, Geriatric Hematology
University of Zurich
Observational
208
Bern, Zurich
2025-12-12
Recruiting
ICU Background Early Awareness for Critical deterioratiON
NCT07119411Respiratory Failure, Circulatory Failure, Mortality, Organ Dysfunction
ETH Zurich
Observational
1,962
Bern
2025-12-01
Not yet open
University of Zurich
Phase 2
98
Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2025-12-01
Recruiting
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
NCT06936774LARS - Low Anterior Resection Syndrome, Rectal Cancer Surgery, Rectal Cancer, Quality of Life (QOL)
University Hospital, Basel, Switzerland
Phase 3
140
Basel, Bern, Lucerne, Winterthur
2025-12-01
Recruiting
Amgen
Phase 3
750
Bern, Lausanne, Sankt Gallen, Zurich
2025-11-28
Recruiting
Hoffmann-La Roche
Phase 3
250
Bern, Olten, Sankt Gallen
2025-11-27
Recruiting
Aarhus University Hospital
Phase 3
1,652
Bern
2025-11-26
Recruiting
DCB Research AG
Observational
350
Bern
2025-11-20
Recruiting
Neurofeedback-based Visual Restoration Therapy
NCT07237412Visual Field Defect Homonymous Bilateral
Adrian Guggisberg
Not applicable
14
Bern, Geneva
2025-11-17
Recruiting
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
NCT07280143Breast Cancer Survivors, Colorectal (Colon or Rectal) Cancer Survivors, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern
Observational
200
Bern
2025-11-14
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Bern, Geneva, Lausanne, Lugano
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Bern, Lausanne
2025-11-11
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Olten, Basel, Bern
2025-11-10
Recruiting
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
NCT06954610Ischemic Stroke, Atrial Fibrillation, Cerebrovascular Disorders, Brain Diseases
Insel Gruppe AG, University Hospital Bern
Observational
500
Bern
2025-11-04
Recruiting
Centre Hospitalier Universitaire Vaudois
Phase 2
59
Basel, Aarau, Bern, Fribourg, Lucerne, Lausanne, Zurich
2025-11-03
Recruiting
Penumbra Inc.
Observational
200
Basel, Bern
2025-11-01
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
DrugAvacincaptad Pegol
ONL Therapeutics
Phase 2
324
Bern, Binningen, Lausanne, Zurich
2025-10-28
Recruiting
Takeda
Phase 3
70
Bern, Lausanne, Zurich
2025-10-27
Recruiting
Swiss Cancer Institute
Phase 2
24
Aarau, Basel, Bellinzona, Bern, Lausanne, Sankt Gallen, Winterthur, Zurich
2025-10-27
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Bern, Sankt Gallen, Bellinzona, Geneva
2025-10-23
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
816
Bern
2025-10-17
Recruiting
Exploring Multidimensional Trajectories in People With Low Back Pain
NCT07176845Acute Low Back Pain, Chronic Low Back Pain (CLBP)
Bern University of Applied Sciences
Observational
600
Bern
2025-10-16
Recruiting
Marc Blondon
Phase 3
9,200
Baden, Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Neuchâtel
2025-10-15
Recruiting
The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention
NCT07036692Nutritional and Metabolic Diseases, Overweight
University of Bern
Not applicable
120
Bern
2025-10-09
Recruiting
Sanofi
Phase 3
980
Bern
2025-10-08
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
80
Bern, Heiligenschwendi
2025-10-07
Recruiting
Linezolid Plus Standard of Care
NCT06958835Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
DrugLinezolid
University Hospital, Basel, Switzerland
Not applicable
606
Aarau, Basel, Bern, Geneva, Delémont, Sankt Gallen, Lausanne, Winterthur
2025-10-06
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Bern, Geneva, Lucerne
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bern, Sankt Gallen
2025-10-03
Recruiting
Sanofi
Phase 3
980
Basel, Bern
2025-10-01
Active, closed
Fabiën Belle
Observational
12,150
Aarau, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich, Bellinzona
2025-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bern, Sankt Gallen, Zurich
2025-10-01
Not yet open
Medical University Innsbruck
Not applicable
80
Bern, Geneva
2025-09-30
Recruiting
CT-guided Lung Biopsy Risk Optimization Method
NCT06340178Pneumothorax, Biopsy, Needle, Risk Factors, Radiology, Interventional
Insel Gruppe AG, University Hospital Bern
Not applicable
198
Bern
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Bern
2025-09-28
Recruiting
Study on a Digital Ultra-Brief Intervention During Wait Times for Psychotherapy
NCT07167849Depressive Disorders, Anxiety Disorders
University of Bern
Not applicable
312
Bern
2025-09-22
Not yet open
ZeroOCD: Learn to Overcome Contamination OCD With Your Smartphone
NCT07194473Obsessive Compulsive Disorder (OCD)
VU University of Amsterdam
Not applicable
189
Bern
2025-09-21
Recruiting
BeOne Medicines
Phase 3
500
Bern, Zurich
2025-09-04
Recruiting
The Motor Activity - Subjective Energy (MASE) Project
NCT07059234Depressive Disorder, Major
University of Bern
Not applicable
180
Bern
2025-09-02
Recruiting
University of Bern
Not applicable
80
Bern
2025-09-01
Not yet open
Larissa University Hospital
Observational
100
Bern
2025-09-01
By invitation
Urethral Vascularization and Urodynamics
NCT07185698Stress Urinary Incontinence, Ultrasound, Vascularisation, Urodynamic Exam
Insel Gruppe AG, University Hospital Bern
Not applicable
70
Bern
2025-09-01
Recruiting
A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth
NCT07437417Gingival Recession, Connective Tissue Defect
University of Bern
Not applicable
60
Bern
2025-09-01
Not yet open
A Quick and Reliable Eye Movement Test to Help Diagnose ADHD in Children.
NCT07136259Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD)
Onovis Augenpraxis
Observational
100
Bern
2025-09-01
Not yet open
hemotune AG
Not applicable
16
Bern, Zurich
2025-09-01
Active, closed
Merz Therapeutics GmbH
Phase 3
997
Bern, Zollikon
2025-08-21
Active, closed
Merz Therapeutics GmbH
Phase 3
808
Bern, Zollikon
2025-08-21
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
30
Bern
2025-08-15
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
50
Bern
2025-08-07
Recruiting
University of Bern
Not applicable
196
Bern
2025-08-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Basel, Bellinzona, Bern, Zurich
2025-08-05
Not yet open
Implantica CE Reflux Ltd.
Not applicable
200
Bern
2025-08-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
40
Bern
2025-08-01
Recruiting
University of Fribourg
Observational
800
Bern, Fribourg, Lausanne
2025-08-01
Active, closed
Insel Gruppe AG, University Hospital Bern
Not applicable
58
Bern
2025-08-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
40
Bern
2025-08-01
Not yet open
Resting Energy Expenditure in Postmenopausal Women
NCT06905886Postmenopause, Energy Expenditure, Hormone Replacement Therapy
Insel Gruppe AG, University Hospital Bern
Observational
37
Bern
2025-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
4,390
Basel, Bern, Zurich
2025-07-31
Active, closed
Amgen
Phase 3
12,800
Basel, Bern, Geneva, Lausanne, Lugano, Zurich
2025-07-25
Recruiting
Pfizer
Phase 3
714
Bern, Zurich
2025-07-23
Recruiting
Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder
NCT07071779Alcohol Use Disorder (AUD), Cocaine Use Disorder (CUD), Substance Use Disorder (SUD)
University of Bern
Not applicable
210
Bern
2025-07-23
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
50
Bern
2025-07-14
Recruiting
University Children's Hospital Basel
Not applicable
750
Aarau, Basel, Bern, Chur, Geneva, Lausanne, Lucerne, Sankt Gallen
2025-07-12
Active, closed
Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations
NCT07039123Primary Prevention of Cardiovascular Disease
University of Bern
Not applicable
205
Bern, Fribourg
2025-07-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Basel, Bern, Geneva, Lucerne, Sankt Gallen
2025-07-02
Recruiting
National Institute of Oncology, Hungary
Not applicable
250
Bern
2025-07-01
Recruiting
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
NCT06963203Graves Disease, Amiodarone-Induced Thyrotoxicosis, Thyroidectomy
Andrea Goldmann
Observational
486
Zurich, Basel, Bern, Geneva, Lausanne, Liestal, Männedorf, Mendrisio
2025-07-01
Recruiting
Azafaros B.V.
Phase 3
72
Bern
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
147
Bern
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
Bern
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2025-06-25
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bern, Lausanne, Zurich
2025-06-23
Active, closed
AbbVie
Phase 3
573
Lucerne, Sankt Gallen, Bern
2025-06-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
110
Aarau, Basel, Bern, Lucerne, Lugano, Sankt Gallen
2025-06-01
Active, closed
University of Bern
Not applicable
23
Bern
2025-06-01
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Basel, Bern, Sankt Gallen
2025-05-27
Recruiting
Swiss Cancer Institute
Observational
30
Aarau, Baden, Basel, Bern, Biel, Chur, Lucerne, Sankt Gallen
2025-05-25
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Oligometastatic Squamous Cell Carcinoma of the Head and Neck
DrugPembrolizumab
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
200
Aarau, Bellinzona, Bern, Chur, Lucerne, Winterthur, Zurich
2025-05-23
Recruiting
Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair
NCT06332911Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture, Abdominal Aortic Aneurysm Without Rupture, Thoracic Aortic Aneurysm Without Rupture
Rede Optimus Hospitalar SA
Observational
30
Bern
2025-05-19
Recruiting
Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions
NCT07072026Intracranial Stenosis, Intracranial Atherosclerotic Disease
Insel Gruppe AG, University Hospital Bern
Observational
80
Bern
2025-05-15
Recruiting
Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients
NCT06839794Childhood Cancer, Cancer-related Problem/Condition, Cognitive Side Effects of Cancer Therapy, Physical Activity
University of Bern
Not applicable
70
Bern
2025-05-10
Recruiting
Takeda
Phase 3
225
Basel, Bern, Zurich
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Aarau, Basel, Bellinzona, Bern, Geneva, Zurich
2025-05-05
Active, closed
Effect of Menopausal Hormone Therapy on Sleep
NCT07674316Menopause, Sleep Quality, Psychological Wellbeing
Insel Gruppe AG, University Hospital Bern
Observational
172
Bern
2025-05-01
By invitation
Novo Nordisk A/S
Observational
1,250
Bern, Geneva, Lucerne, Lugano, Neuchâtel, Olten, Sankt Gallen, Zurich
2025-05-01
Recruiting
PRF as Adjunct to Subgingival Instrumentation in Step 2 Periodontal Therapy
NCT07013682Periodontitis, Periodontal Inflammation, Periodontal Attachment Loss
University of Bern
Not applicable
20
Bern
2025-05-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
148
Bern
2025-05
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
20
Bern, Zurich
2025-04-24
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
302
Bern, Zurich
2025-04-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
150
Basel, Bern, Geneva, Lugano
2025-04-14
Recruiting
University of Bern
Not applicable
50
Bern
2025-04-01
Not yet open
Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques
NCT06705010Aging, Brain Metabolic Disorder, Carotid Stenosis, Alzheimer Disease
Insel Gruppe AG, University Hospital Bern
Not applicable
140
Bern
2025-04-01
Recruiting
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Ovarian Endometrioid Carcinoma, High-grade Serous Ovarian Carcinoma (HGSOC)
Swiss GO Trial Group
Not applicable
60
Baden, Basel, Sankt Gallen, Frauenfeld, Aarau, Bern, Fribourg, Lucerne
2025-03-31
Active, closed
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T)
DrugN-Acetyl-L-Leucine
IntraBio Inc
Phase 3
60
Bern
2025-03-18
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Baden, Basel, Bern, Biel, Geneva, Lausanne, Lucerne, Lugano
2025-03-14
Active, closed
Novartis Pharmaceuticals
Phase 2
126
Basel, Bern
2025-03-13
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Bern, Sankt Gallen
2025-03-12
Recruiting
Coronary Artery Disease Assessment Strategies in TAVI Patients
NCT06559332Transcatheter Aortic Valve Replacement, Coronary Artery Disease, Heart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern
Not applicable
546
Bern
2025-03-11
Recruiting
Comparative Efficacy of BRT and CBT-I for Insomnia
NCT06767137Insomnia Disorders, Insomnia Disorder, Insomnia, Insomnia Chronic
Christoph Nissen
Not applicable
160
Bern, Geneva
2025-03-10
Recruiting
Exploring the Role of the Prefrontal Cortex in Decision-Making
NCT07080489Depressive Disorder, Major Depressive Disorder, Healthy Volunteer, Aging
University of Bern
Not applicable
444
Bern
2025-03-04
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Basel, Bellinzona, Bern
2025-02-27
By invitation
University of Zurich
Phase 1
30
Bern, Zurich
2025-02-25
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Bern, Lausanne, Zurich
2025-02-24
Recruiting
Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in Older Adults (60-85) With Mild Memory Impairment
NCT06669546Cognitive Decline, Alzheimer Disease, Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI)
University of Bern
Not applicable
60
Bern
2025-02-21
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
203
Bern
2025-02-20
Recruiting
University Hospital, Basel, Switzerland
Not applicable
972
Basel, Bern, Sankt Gallen, Lausanne, Zurich, Aarau, Geneva
2025-02-20
Recruiting
Hannover Medical School
Not applicable
274
Bern, Zurich
2025-02-19
Recruiting
GlaxoSmithKline
Phase 2
120
Bern, Geneva
2025-02-18
Active, closed
Lia Bally
Not applicable
96
Bern
2025-02-18
Recruiting
Bayer
Phase 2
111
Bern, Geneva, Zurich
2025-02-13
Recruiting
University Hospital, Basel, Switzerland
Not applicable
400
Aarau, Basel, Bern, Biel, Chur, Geneva, Lausanne, Liestal
2025-02-10
Recruiting
University of Zurich
Phase 2
120
Zurich, Aarau, Bellinzona, Bern, Geneva, Neuchâtel, Winterthur
2025-02-04
Active, closed
The Leeds Teaching Hospitals NHS Trust
Observational
550
Bern, Lucerne
2025-02-04
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 2
70
Bern
2025-02-03
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
40,000
Bern, Aarau, Lausanne
2025-02-01
Recruiting
Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF)
NCT06679283Peri-Implantitis, Bone Resorption, Platelet-Rich Fibrin
University of Bern
Not applicable
40
Bern
2025-02-01
Recruiting
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
NCT05940766Pediatric Oncology Patients With Risk for Infections
Insel Gruppe AG, University Hospital Bern
Not applicable
250
Bern
2025-02-01
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Basel, Bern, Zurich
2025-01-31
Recruiting
A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
NCT06325293Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
Christoph Berger
Not applicable
376
Aarau, Basel, Bern, Fribourg, Geneva, Lucerne, Sankt Gallen, Lausanne
2025-01-28
Recruiting
Takeda
Phase 3
70
Lausanne, Bern, Zurich
2025-01-22
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Baden, Basel, Bellinzona, Bern, Fribourg, Lausanne, Sankt Gallen, Winterthur
2025-01-15
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bern, Lugano
2025-01-13
Recruiting
Brain Aging in Phenylketonuria
NCT06969209Phenylketonuria (PKU)
Insel Gruppe AG, University Hospital Bern
Observational
90
Bern
2025-01-13
Active, closed
Pfizer
Phase 3
1,035
Basel, Bern, Frauenfeld, Aarau, Chur, Münsterlingen, Winterthur
2025-01-06
Recruiting
Takeda
Phase 3
396
Basel, Bern, Zurich
2025-01-02
Recruiting
Skin Cancer and Hyperthermia and Radiotherapy
NCT06384053Basal Cell Carcinoma, Squamous Cell Carcinoma Skin, Non-melanoma Skin Cancer
Kantonsspital Winterthur KSW
Not applicable
100
Aarau, Winterthur, Bern, Lucerne
2025-01-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
34
Bern
2025-01-01
Recruiting
Administration of Intranasal Midazolam for Anxiety in Palliative Care
NCT06330584Anxiety, Acute Anxiety, Palliative Care
DrugMidazolam
Insel Gruppe AG, University Hospital Bern
Phase 2
36
Basel, Bern, Zurich
2024-12-20
Active, closed
argenx
Phase 3
154
Bern
2024-12-18
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Bern, Lausanne, Zurich
2024-12-12
Active, closed
Amgen
Phase 3
707
Bellinzona, Bern, Chur, Lausanne, Sankt Gallen
2024-12-09
Recruiting
Closed-loop in Adults With Type 2 Diabetes
NCT06579404Type 2 Diabetes Treated With Insulin
University of Cambridge
Not applicable
224
Bern
2024-12-06
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
118
Bern
2024-12-03
Active, closed
AbbVie
Observational
1,314
Reinach, Bad Zurzach, Lausanne, Zollikon, Zurich, Lugano, Sion, Bern
2024-11-26
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
50
Bern, Zurich
2024-11-21
Active, closed
Daiichi Sankyo
Phase 3
700
Bern, Lazern 16
2024-11-19
Active, closed
Assessment of Organ Failure Risk Predictions in ICU
NCT06814327Circulatory Failure, Respiratory Failure, Renal Failure
ETH Zurich
Observational
499
Bern
2024-11-18
Active, closed
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
NCT06584513Benzodiazepines Deprescribing, Sleep Problems
Insel Gruppe AG, University Hospital Bern
Not applicable
470
Bern
2024-11-18
Active, closed
Novartis Pharmaceuticals
Phase 1
110
Bellinzona, Bern
2024-11-11
Active, closed
Abbott Medical - VERITAS Study
NCT06707688Atrial Fibrillation (AF), Stoke
Abbott Medical Devices
Not applicable
458
Bern
2024-11-07
Recruiting
Digital Device Reading Skin Prick Test
NCT06743737Allergy Skin Prick Test Reading
Insel Gruppe AG, University Hospital Bern
Observational
200
Bern
2024-11-01
Recruiting
PeRfusiOn Post tHrombEcTomy (PROPHET)
NCT06691230Stroke, Acute, Ischemic
Insel Gruppe AG, University Hospital Bern
Observational
279
Basel, Bern
2024-11-01
Recruiting
Antonio Leidi
Not applicable
222
Geneva, Bern, Fribourg, Lugano
2024-10-22
Recruiting
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980Metastatic Castration-resistant Prostate Cancer
DrugDarolutamide
Swiss Cancer Institute
Phase 2
162
Aarau, Baden, Bellinzona, Bern, Chur, Geneva, Lausanne, Lucerne
2024-10-22
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
40
Bern
2024-10-21
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Arzo, Bern, Geneva, Zurich
2024-10-14
Active, closed
Incyte Corporation
Phase 3
349
Bern, Buochs, Zurich
2024-10-10
Active, closed
Gilead Sciences
Phase 3
609
Bern, Lausanne, Zurich
2024-10-09
Active, closed
Novartis Pharmaceuticals
Phase 1
54
Bern
2024-10-08
Active, closed
Gilead Sciences
Phase 3
600
Bern, Geneva, Lausanne
2024-10-08
Recruiting
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NCT06629207Parkinson Disease, REM Sleep Behavior Disorder, Dementia, Lewy Body
Insel Gruppe AG, University Hospital Bern
Not applicable
20
Bern
2024-10-07
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Olten, Lugano, Bern, Sankt Gallen, Zurich
2024-10-04
Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Edwards Lifesciences
Observational
500
Bern
2024-10-01
Recruiting
Deprescribing Inappropriate Proton Pump Inhibitors
NCT06129474Inappropriate Prescribing, Reflux Disease, Proton Pump Inhibitors
University of Bern
Not applicable
400
Bern
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Geneva, Basel, Bern, Zurich
2024-10-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 2
99
Bern
2024-10-01
Recruiting
Hoffmann-La Roche
Observational
842
Bern, Zurich
2024-09-26
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Bern
2024-09-19
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
400
Bern
2024-09-18
Recruiting
University of Kiel
Not applicable
60
Bern, Zurich
2024-09-05
Recruiting
STIMPulseControl Ancillary Speech Study
NCT06561919Parkinson Disease, Impulse Control Disorder
Steffen Paschen
Not applicable
60
Bern, Zurich
2024-09-05
Recruiting
AbbVie
Phase 2
590
Zurich, Bern
2024-09-04
Recruiting
University of Bern
Not applicable
38
Bern
2024-08-28
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
200
Bern
2024-08-27
Active, closed
Kite, A Gilead Company
Phase 3
452
Bern
2024-08-23
Recruiting
Sanofi
Phase 3
160
Basel, Bern
2024-08-21
Active, closed
Incyte Corporation
Phase 1
37
Bern, Zurich
2024-08-08
Recruiting
Neuropsychological Patterns of Suicide Ideators and Suicide Attempters
NCT06248268Inhibitory Control, Locus of Control, Self Efficacy, Suicide, Attempted
University of Bern
Observational
180
Bern
2024-08-08
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
28
Bern
2024-08-05
Recruiting
University Medical Center Groningen
Phase 3
300
Bern, Fribourg, Geneva, Zurich
2024-07-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Basel, Bern
2024-07-24
Active, closed
OncoVerity, Inc.
Phase 2
140
Bern, Fribourg, Sankt Gallen
2024-07-22
Recruiting
SWIFT - SWIss Factor XIII Trial in PPH
NCT06481995Postpartum Hemorrhage, Coagulation Disorder, Coagulation Factor Deficiency, Hemorrhage
Christian Haslinger
Phase 4
988
Geneva, Winterthur, Zollikerberg, Zurich, Baden, Basel, Bern, Lausanne
2024-07-09
Recruiting
University Hospital, Basel, Switzerland
Not applicable
498
Basel, Bern, Geneva, Zurich
2024-07-04
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 2
100
Bern
2024-07-01
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Basel, Bern
2024-07-01
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Bern, Lucerne
2024-06-26
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Bern
2024-06-25
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Basel, Bellinzona, Bern, Zurich
2024-06-19
Recruiting
Platelet Function After Cardiac Surgery.
NCT06405516Platelet Dysfunction
Insel Gruppe AG, University Hospital Bern
Not applicable
40
Bern
2024-06-12
Recruiting
X4 Pharmaceuticals
Phase 3
176
Bern
2024-06-06
Active, closed
Amgen
Phase 3
563
Basel, Bern, Mendrisio, Sankt Gallen
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Basel, Bern, Sankt Gallen, Zurich
2024-06-05
Recruiting
SASL Swiss Cirrhosis Cohort
NCT06092385Liver Cirrhosis
University Hospital, Basel, Switzerland
Observational
3,000
Lugano, Basel, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2024-06-04
Recruiting
PENTA Foundation
Not applicable
3,080
Basel, Bern, Geneva, Sankt Gallen, Zurich
2024-05-28
Active, closed
CPAx: Responsiveness and Minimal Clinically Important Difference
NCT06419699Muscle Weakness, Critical Illness Myopathy, Critical Illness Polyneuropathy, Critical Illness Polyneuromyopathy
Insel Gruppe AG, University Hospital Bern
Observational
120
Bern
2024-05-23
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bellinzona, Bern
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Bern, Sankt Gallen, Villars-sur-Glâne
2024-05-21
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Bern, Geneva, Sankt Gallen
2024-05-17
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Baden, Basel, Bern, Lucerne, Lugano, Sankt Gallen, Winterthur, Zurich
2024-05-15
Recruiting
Early Life Intervention in Pediatrics Supported by E-health - SMOKE
NCT06311162Smoking Reduction, Asthma in Children, Wheezing, Non-Communicable Disease
Insel Gruppe AG, University Hospital Bern
Not applicable
160
Bern
2024-05-07
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lugano, Lausanne, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich
2024-05-01
Active, closed
Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness
NCT06739499Pandemic, COVID-19, Infections, Zoonoses, Epidemic Disease
University of Bern
Observational
2,157
Bern
2024-04-29
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
30
Bern
2024-04-20
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Bern
2024-04-16
Recruiting
Colchicine After Electrocardioversion for Atrial Fibrillation
NCT05890664Atrial Fibrillation, Cardiac Arrhythmia
DrugColchicine
University Hospital, Basel, Switzerland
Phase 3
416
Bruderholz, Basel, Bern, Lausanne, Lucerne, Olten, Rheinfelden, Solothurn
2024-04-14
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
120
Bern
2024-04-09
Recruiting
University of Bern
Not applicable
156
Bern
2024-03-25
Active, closed
AbbVie
Phase 2
156
Bern
2024-03-23
Recruiting
Medical University Innsbruck
Not applicable
1,350
Bern
2024-03-12
Active, closed
Swiss Cancer Institute
Not applicable
64
Aarau, Basel, Bellinzona, Bern, Chur, Fribourg, Geneva, Lausanne
2024-03-12
Active, closed
Study on Regulated Cannabis Sales in Pharmacies
NCT06120855Marijuana Smoking, Cannabis, Cannabis Use
University of Bern
Not applicable
1,177
Bern, Lucerne
2024-03-11
Recruiting
Safety and Normative Data With Neos™
NCT07258212Neuro-Ophthalmology
machineMD AG
Observational
200
Bern
2024-03-07
Recruiting
Takeda
Phase 2
268
Basel, Bern
2024-03-05
Active, closed
AstraZeneca
Phase 3
594
Bern, Geneva, Lausanne, Zurich
2024-03-04
Active, closed
Impact of TAVI on the Gut Microbiota and Its Metabolites
NCT07565077Calcific Aortic Valve Disease, Inflammation, Dysbiosis, TAVI
Insel Gruppe AG, University Hospital Bern
Observational
40
Bern
2024-03-01
Recruiting
Takeda
Phase 3
50
Bern
2024-03-01
Recruiting
The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis.
NCT06821217Endometriosis, Pain, Quality of Life, Life Style
Insel Gruppe AG, University Hospital Bern
Not applicable
308
Bern
2024-03-01
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Chur, Basel, Bern, Lausanne, Zurich
2024-02-21
Recruiting
Early Life Intervention in Pediatrics Supported by E-health
NCT06208345Adiposity, Childhood Obesity, Adolescent Obesity, Non-communicable Disease
Insel Gruppe AG, University Hospital Bern
Not applicable
148
Bern
2024-02-16
Active, closed
CarThera
Phase 3
560
Bern, Lausanne
2024-01-29
Recruiting
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
NCT06166706Mechanical Ventilation Complication, Pediatric ALL, Pulmonary Complication, Perioperative/Postoperative Complications
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
10,000
Bern
2024-01-29
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
800
Bern
2024-01-22
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
15
Bern, Zurich
2024-01-11
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,182
Basel, Bern, Lucerne, Sankt Gallen, Zurich
2024-01-11
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
2,800
Aarau, Basel, Bern, Fribourg, Geneva, Lausanne, Lucerne, Lugano
2024-01-01
Recruiting
University Hospital, Basel, Switzerland
Not applicable
200
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen, Sion
2024-01-01
Recruiting
Comparison Between Two Medical Devices for Labor Induction After Previous C-section
NCT06506721Delivery, Obstetric, Cesarean Section, Obstetric Delivery
Insel Gruppe AG, University Hospital Bern
Not applicable
137
Bern
2023-12-29
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Basel, Bern, Geneva, Lugano
2023-12-27
Active, closed
Affera Global Registry
NCT06026345Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
540
Bern
2023-12-22
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
Baden, Basel, Bern, Sankt Gallen, Sion, Solothurn, Winterthur
2023-12-20
Recruiting
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
NCT05955365Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor
DrugsDOAC·Aspirin
Insel Gruppe AG, University Hospital Bern
Phase 4
3,010
Lugano, Basel, Bern, Geneva, Zurich
2023-12-18
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
322
Bern
2023-12-15
Active, closed
Sanofi
Phase 3
1,655
Bern
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Baden, Sankt Gallen, Winterthur, Basel, Bern
2023-12-12
Recruiting
AbbVie
Phase 3
110
Zurich, Bern
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Basel, Bellinzona, Chur, Bern
2023-12-06
Active, closed
Gilead Sciences
Phase 2
176
Bern
2023-12-05
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Olten, Bern, Sankt Gallen
2023-12-01
Recruiting
Impact of Gonadotoxic Therapies on Fertility
NCT05885048Cancer, Fertility Issues, Fertility Preservation, Toxicity Due to Chemotherapy
Michael von Wolff
Observational
7,000
Bern
2023-12-01
Recruiting
Thomas Riva
Not applicable
1,192
Aarau, Lucerne, Bern, Lausanne
2023-12-01
Active, closed
The Effect of Smoking on Peri-implantitis
NCT06150066Periimplantitis, Microbial Colonization, Cytokines
Mustafa Kemal University
Observational
96
Bern
2023-11-21
Recruiting
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
NCT06333275Vaccine Immunity in CAR-T Cell Therapy Recipients
Insel Gruppe AG, University Hospital Bern
Observational
80
Bern
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,902
Baden, Basel, Bern, Frauenfeld
2023-11-14
Active, closed
The PIFPAF-PFA Study
NCT05986526Persistent Atrial Fibrillation
Insel Gruppe AG, University Hospital Bern
Not applicable
206
Baden, Basel, Bern, Lausanne, Sankt Gallen, Zurich
2023-11-13
By invitation
B-free Multistage Trial
NCT06037564HIV, Drug Resistance, Drug Drug Interaction
Insel Gruppe AG, University Hospital Bern
Phase 4
210
Aarau, Basel, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-11-13
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Olten, Bern, Sankt Gallen
2023-11-10
Active, closed
AstraZeneca
Phase 3
863
Baden, Basel, Bern, Fribourg, Sankt Gallen
2023-11-09
Recruiting
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease
NCT06027333Interstitial Lung Disease, Fibrotic Lung Disease, Self Efficacy, Self-management
Berner Reha Zentrum AG
Observational
80
Bern
2023-11-08
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Bern, Geneva
2023-11-03
Recruiting
Institut Curie
Not applicable
600
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2023-11-02
Recruiting
Biogen
Observational
908
Bern
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Basel, Bern, Geneva
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Bern, Sankt Gallen, Zurich
2023-10-25
Active, closed
Stichting European Myeloma Network
Phase 3
759
Basel, Bern, Lausanne, Zurich
2023-10-10
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bern, Lausanne, Zurich
2023-10-02
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 1/2
94
Bern
2023-09-28
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Basel, Bern, Geneva
2023-09-14
Active, closed
Bristol-Myers Squibb
Phase 3
774
Bern, Sankt Gallen
2023-09-11
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Baden, Bern, Sankt Gallen, Villars-sur-Glâne
2023-09-07
Recruiting
Gilead Sciences
Phase 3
402
Bern, Zurich
2023-09-07
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Basel, Bern, Lausanne, Lugano, Zurich
2023-09-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
250
Bern
2023-08-24
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Bern, Sankt Gallen, Zurich
2023-08-17
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Bern, Sankt Gallen, Zurich
2023-08-17
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
174
Bern, Zurich
2023-08-11
Recruiting
University of Bern
Observational
60
Bern
2023-08-07
Recruiting
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
NCT05894070Laryngeal Cancer, Hypopharyngeal Cancer
Insel Gruppe AG, University Hospital Bern
Observational
100
Bern, Zurich
2023-08-02
Recruiting
Stepcare Extended Follow-up Substudy
NCT06207942Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain, Cognitive Impairment, Caregiver Burden
Region Skane
Not applicable
600
Bern, Sankt Gallen
2023-08-01
Active, closed
AbbVie
Phase 3
1,014
Basel Town, Sankt Gallen, Bern
2023-07-25
Recruiting
ClassIntra® for Better Outcomes in Surgery - CIBOSurg
NCT05818332Perioperative Patient Safety
University Hospital, Basel, Switzerland
Observational
1,800
Basel, Bern, Chur, Geneva, Lausanne, Lucerne, Lugano, Zurich
2023-07-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
150
Bern
2023-07-01
Recruiting
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NCT05732701Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease
Insel Gruppe AG, University Hospital Bern
Not applicable
2,788
Biel/Bienne, Bern
2023-06-27
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
12
Bern
2023-06-24
Active, closed
AbbVie
Phase 3
1,328
Sankt Gallen, Zurich, Bern
2023-06-21
Recruiting
Hoffmann-La Roche
Phase 1/2
320
Basel, Bern
2023-06-20
Recruiting
CSL Behring
Observational
500
Bern
2023-06-15
Active, closed
AbbVie
Observational
1,019
Meyrin, Sankt Gallen, Lausanne, Zurich, Bern
2023-06-09
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Bern
2023-06-06
Recruiting
Baris Gencer
Not applicable
220
Basel, Bern, Lausanne, Geneva
2023-06-01
Recruiting
Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome
NCT05851326Myofascial Pain Syndrome - Lower Back, Myofascial Pain Syndrome - Neck, Myofascial Pain Syndrome - Tension Headache
Sobet AG
Not applicable
126
Bern, Meyrin, Zurich
2023-05-25
Recruiting
Pfizer
Phase 2
100
Bern, Lausanne, Zurich
2023-05-17
Active, closed
Boehringer Ingelheim
Phase 1
59
Bern, Geneva, Lausanne
2023-05-11
Recruiting
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fracture
NCT05769114SPINAL Fracture, Burst Fracture, Spinal Instability of Thoracolumbar Region
Insel Gruppe AG, University Hospital Bern
Not applicable
52
Bern, Sankt Gallen
2023-04-18
Recruiting
Structured Shared Decision Making for Patients Undergoing SAVR or TAVR
NCT05711186Aortic Valve Stenosis, Symptomatic Aortic Stenosis
Insel Gruppe AG, University Hospital Bern
Not applicable
140
Bern, Biel
2023-04-17
Recruiting
Vrije Universiteit Brussel
Not applicable
252
Bern
2023-04-13
Recruiting
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
NCT05726786Bladder Cancer, Interstitial Cystitis, Painful Bladder Syndrome, Neurogenic Bladder
Centre Hospitalier Universitaire Vaudois
Phase 3
232
Lausanne, Bern, Geneva, Rennaz
2023-04-10
Recruiting
Takeda
Phase 2/3
500
Barmelweid, Lugano, Bern
2023-04-05
Recruiting
University Hospital, Geneva
Observational
400
Bellinzona, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-04-01
Recruiting
Pierre Mégevand
Not applicable
30
Bern, Geneva
2023-03-30
Active, closed
Insel Gruppe AG, University Hospital Bern
Not applicable
36
Basel, Bellinzona, Bern, Winterthur, Zurich
2023-03-29
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
Bellinzona, Bern, Geneva, Sankt Gallen
2023-03-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
641
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2023-03-17
Recruiting
Benoit Guery
Phase 3
100
Basel, Bern, Fribourg, Lucerne, Sankt Gallen, Lausanne, Zurich, Sion
2023-03-15
Active, closed
University of Zurich
Not applicable
49
Liestal, Bern, Lucerne, Winterthur, Zurich
2023-03-10
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Basel, Bern, Geneva, Lucerne, Lugano
2023-03-09
Active, closed
Bristol-Myers Squibb
Phase 3
579
Bern, Chur, Lausanne
2023-03-06
Recruiting
Takeda
Phase 3
160
Bern
2023-03-06
Active, closed
Insel Gruppe AG, University Hospital Bern
Observational
120
Bern
2023-02-27
Recruiting
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163Gastroesophageal Reflux Disease (GERD)
Implantica CE Reflux Ltd.
Observational
2,500
Bern
2023-02-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
553
Basel, Geneva, Lausanne, Zurich, Lugano, Bern
2023-02-20
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Aarau, Basel, Bern, Lausanne, Sankt Gallen
2023-02-15
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Bern, Lucerne, Sankt Gallen, Zurich
2023-02-13
Recruiting
Medtronic Cardiovascular
Not applicable
400
Bern
2023-02-07
Active, closed
University Hospital, Basel, Switzerland
Not applicable
920
Basel, Aarau, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-02-05
Recruiting
Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery
NCT05595954Postoperative Delirium, Postoperative Stroke, Postoperative Cognitive Dysfunction
University Hospital, Basel, Switzerland
Observational
500
Basel, Bern
2023-01-23
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
200
Bern
2023-01-17
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Basel, Bern, Zurich
2023-01-16
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
Inari Medical
Not applicable
300
Baden, Bern, Lucerne
2023-01-06
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
304
Bern
2023-01-06
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
80
Bern
2023-01-03
Recruiting
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
NCT06273176Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme of Brain, Astrocytoma, Malignant
Erasmus Medical Center
Observational
225
Bern
2023-01-01
Recruiting
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06146738Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme, Adult
Jasper Gerritsen
Observational
1,015
Bern
2023-01-01
Recruiting
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725Glioblastoma, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult
Jasper Gerritsen
Observational
564
Bern
2023-01-01
Recruiting
Technische Universität Dresden
Observational
318,542
Bern
2023-01-01
By invitation
European TIF2.0 Registry
NCT07395219Gastro -Oesophagal Reflux, Laryngo-pharyngeal Reflux
Cleveland Clinic London
Observational
500
Bern
2023-01-01
Recruiting
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT06283927Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme of Brain
DrugsLomustine·Temozolomide
Jasper Gerritsen
Observational
464
Bern
2023-01-01
Recruiting
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
NCT05679206Pre-Eclampsia; Complicating Pregnancy, Antiphospholipid Syndrome in Pregnancy, Pulmonary Hypertension
Insel Gruppe AG, University Hospital Bern
Observational
900
Bern
2022-12-20
Recruiting
Sonja Stieb, MD
Observational
150
Aarau, Bern, Zurich
2022-12-19
Recruiting
University Hospital, Basel, Switzerland
Observational
1,000
Aarau, Lucerne, Basel, Bern, Rothrist, Sankt Gallen, Zurich
2022-12-16
Active, closed
Calmy Alexandra
Phase 4
225
Basel, Bern, Geneva, Sankt Gallen, Lausanne, Zurich, Lugano
2022-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Bern, Zurich
2022-12-09
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
180
Bern, Winterthur, Zurich
2022-11-30
Active, closed
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
NCT05688280Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer, Soft Tissue Sarcoma
DrugIP-001
Immunophotonics, Inc.
Phase 1/2
42
Bellinzona, Bern, Chur, Sankt Gallen
2022-11-29
Recruiting
Thomas Jefferson University
Phase 3
660
Bern
2022-11-28
Recruiting
STREAM Trial - Biomarker
NCT05482386Statin Treatment for Primary Prevention
Insel Gruppe AG, University Hospital Bern
Not applicable
500
Bern
2022-11-21
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Aarau, Basel, Bern, Binningen, Geneva, Lausanne, Lucerne, Lugano
2022-11-21
Recruiting
Pfizer
Phase 3
1,060
Bern, Winterthur
2022-11-10
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Bern, La Chaux-de-Fonds, Sankt Gallen, Zurich
2022-10-27
Recruiting
Lindenhofgruppe AG
Not applicable
168
Bern
2022-10-27
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bern, Sankt Gallen
2022-10-25
Active, closed
AbbVie
Observational
400
Zurich, Lugano, Bern
2022-10-20
Recruiting
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Phase 3
72
Bern
2022-10-13
Active, closed
SINGLE SHOT CHAMPION
NCT05534581Paroxysmal Atrial Fibrillation
Insel Gruppe AG, University Hospital Bern
Phase 4
210
Basel, Bern
2022-09-26
Recruiting
Swiss Revision Cohort
NCT07473089Joint (Knee or Hip Replacement), Infection as Complication of Medical Care
Insel Gruppe AG, University Hospital Bern
Observational
329
Aarau, Bern, Fribourg, Geneva, Lausanne
2022-09-23
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Basel, Bern, Sankt Gallen, Zurich
2022-09-19
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Basel, Bern, Sankt Gallen
2022-09-08
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Bern, Lugano, Zurich
2022-09-01
Recruiting
Thalamic-Burst-DBS for Neuropathic Pain
NCT05204472Central Post-stroke Pain, Neuropathic Pain
Insel Gruppe AG, University Hospital Bern
Not applicable
20
Bern
2022-09-01
Active, closed
Amgen
Phase 1
184
Basel, Bern
2022-08-24
Active, closed
The Leadless AV Versus DDD Pacing Study
NCT05498376Cardiac Pacemaker, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases
Insel Gruppe AG, University Hospital Bern
Phase 4
100
Bern
2022-08-23
Recruiting
Early Versus Deferred Aortic Valve Replacement in Patients With Moderate Aortic Stenosis and Mitral Regurgitation
NCT05310461Aortic Valve Replacement in Patients With Moderate Aortic Stenosis Combined With Mitral Regurgitation
Insel Gruppe AG, University Hospital Bern
Not applicable
80
Bern, Geneva, Zurich
2022-08-17
Active, closed
Novo Nordisk A/S
Phase 3
412
Bern
2022-08-10
Recruiting
Susanne Rogers
Not applicable
200
Aarau, Bern, Chur, Lucerne, Sankt Gallen, Winterthur
2022-07-29
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Basel, Bern, Sankt Gallen, Zurich
2022-07-22
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
88
Bern
2022-07-18
Active, closed
Incyte Corporation
Phase 1
291
Bellinzona, Bern, Lausanne
2022-07-05
Recruiting
University of Zurich
Phase 1
15
Zurich, Bern
2022-07-01
Recruiting
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
NCT05357781Hypogammaglobulinemia, Multiple Sclerosis, Fatigue
Insel Gruppe AG, University Hospital Bern
Observational
106
Bern
2022-07-01
Recruiting
IntraBio Inc
Phase 3
53
Bern
2022-06-30
Active, closed
Swiss Cancer Institute
Phase 2
46
Zurich, Baden, Basel, Bellinzona, Bern, Chur, Geneva, Lucerne
2022-06-24
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
210
Bern, Zurich
2022-06-21
Recruiting
STREAM Trial - Subclinical Atherosclerosis
NCT05482399Statin Treatment for Primary Prevention
Insel Gruppe AG, University Hospital Bern
Not applicable
500
Bern
2022-06-21
Recruiting
University of Bern
Observational
3,000
Basel, Bern, Geneva
2022-06-20
Active, closed
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
NCT04971772Peripheral Arterial Disease, Superficial Femoral Artery Stenosis, Angiopathy, Peripheral
Cardionovum GmbH
Observational
150
Bern, Neuchâtel
2022-06-08
Recruiting
Swiss Society of Dermatology and Venereology
Observational
700
Basel, Bern, Buochs, Fribourg, Lausanne, Lucerne, Sankt Gallen, Uster
2022-06-02
Recruiting
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases
NCT05406063Radiation Therapy, Bone Metastases, Pain
Kantonsspital Winterthur KSW
Not applicable
162
Winterthur, Bern
2022-06-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
60
Bern, Zurich
2022-05-24
Recruiting
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
NCT04043598Subarachnoid Hemorrhage, Critical Illness, Infusion Fluid, Sodium Disorder
Insel Gruppe AG, University Hospital Bern
Not applicable
320
Sankt Gallen, Bern, Geneva
2022-05-24
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Basel, Bern, Lausanne, Sankt Gallen
2022-05-23
Active, closed
University Hospital, Basel, Switzerland
Observational
650
Basel, Bern, Sankt Gallen
2022-05-20
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Bern
2022-05-19
Active, closed
Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD
NCT04932980Wet Age-related Macular Degeneration
DrugAflibercept
Berner Augenklinik
Not applicable
80
Bern
2022-05-09
Active, closed
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
NCT05514028Ovarian Cancer, Ovarian Cyst Benign, Borderline Ovarian Cancer
ZIWIG
Observational
746
Bern
2022-05-04
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Bern
2022-04-27
Recruiting
First in Human Study of T3P-Y058-739 (T3P)
NCT05120596Advanced Solid Tumor
DrugPembrolizumab
T3 Pharmaceuticals AG
Phase 1/2
100
Bern, Lausanne, Zurich
2022-04-26
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
2022-04-13
Recruiting
Bern Human Organoid-Study to Study Host-microbe Interaction
NCT05323357Organoids, Allergy and Immunology, Microbiota
Insel Gruppe AG, University Hospital Bern
Observational
100
Bern
2022-03-31
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Bern, Sankt Gallen, Geneva, Zurich
2022-03-29
Active, closed
Pfizer
Phase 3
854
Bern, Lausanne, Zurich, Baden, Winterthur
2022-03-25
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
100
Bern
2022-03-01
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Basel, Bern, Zurich
2022-02-28
Active, closed
Impact of ILM Peeling in RRD/ I-Peel
NCT04767555Retinal Detachment
Berner Augenklinik
Not applicable
250
Bern
2022-02-23
Active, closed
AstraZeneca
Phase 3
791
Basel, Bern, Lausanne
2022-02-18
Active, closed
UCB Biopharma SRL
Phase 3
113
Basel, Bern, Zurich
2022-02-02
Active, closed
Amgen
Phase 1/2
329
Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
2022-02-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
466
Bern
2022-02-01
Active, closed
Mirror Medacta Shoulder System Pivotal Trial
NCT05062252Arthritis Shoulder, Post-traumatic Arthrosis of Other Joints, Upper Arm
Medacta International SA
Not applicable
100
Bern, Sankt Gallen
2022-01-05
Recruiting
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
NCT06100718Cancer-related Stroke, Paraneoplastic Coagulopathy, Occult Cancer, Ischemic Stroke
Insel Gruppe AG, University Hospital Bern
Observational
370
Lausanne, Basel, Bern
2022-01-01
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
NCT06118723Glioblastoma, High-grade Glioma, Glioblastoma, IDH-wildtype, Glioblastoma, IDH-mutant
Jasper Gerritsen
Observational
784
Bern
2022-01-01
Active, closed
Boston Scientific Corporation
Not applicable
500
Basel, Bern
2021-12-21
Recruiting
Occlutech International AB
Observational
255
Bern
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Basel, Bern
2021-12-16
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
45
Bern
2021-12-13
Active, closed
Alnylam Pharmaceuticals
Observational
207
Bern
2021-12-13
Active, closed
NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)
NCT04969471Segment Elevation Myocardial Infarction (STEMI)
Vesalio
Not applicable
148
Bern, Geneva, Lucerne, Lugano
2021-12-09
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aarau, Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2021-12-09
Active, closed
Echocardiographic Screening of Pregnant Women During Antenatal Care
NCT04936815Valvular Heart Disease, Rheumatic Heart Disease, Pregnancy Complications
Thomas Pilgrim
Not applicable
9,000
Bern
2021-12-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Lausanne, Bellinzona, Chur, Sion, Basel, Bern, Geneva, Lucerne
2021-11-16
Active, closed
Amgen
Phase 3
303
Bern
2021-11-02
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Bern, Basel
2021-11-01
Active, closed
GWT-TUD GmbH
Phase 3
70
Basel, Bellinzona, Bern
2021-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2021-09-15
Recruiting
Metabolic Characterization of Space Occupying Lesions of the Brain
NCT04233788Brain Tumor, Glioma, IDH Mutation
Insel Gruppe AG, University Hospital Bern
Observational
55
Bern
2021-09-01
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Zurich, Aarau, Baden, Basel, Bern, Chur, Lucerne, Sankt Gallen
2021-08-27
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Basel, Bern, Sankt Gallen
2021-08-19
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Basel, Bern, Lugano, Sankt Gallen
2021-08-14
Recruiting
Philipp Schuetz
Not applicable
1,200
Zofingen, Burgdorf, Thun, Lachen, Münsterlingen, Aarau, Bern, Lucerne
2021-08-05
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Bern, Lausanne
2021-07-28
Active, closed
Hoffmann-La Roche
Phase 3
451
Basel, Bern, Binningen, Lausanne, Zurich
2021-07-14
Active, closed
AstraZeneca
Phase 3
315
Bern, Chur, Winterthur
2021-06-30
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Bern
2021-06-30
Recruiting
Corcym S.r.l
Observational
2,150
Bern, Zurich
2021-06-29
Rows per page Showing 1–500 of 722
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swiss investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-switzerland/city/bern

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Switzerland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,249 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 722 of those studies with a site in Bern.

How many clinical trials are recruiting in Bern?

418 of the 722 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 35 have not yet opened recruitment, 256 are active but closed to new participants, and 13 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bern), 722 studies
PhaseStudiesRecruitingShare
Observational22015230.5%
Phase 31968127.1%
Not applicable19212626.6%
Phase 262308.6%
Phase 418132.5%
Phase 11341.8%
Phase 1/21151.5%
Phase 2/31071.4%

Most active sponsors

Lead sponsors with the most studies (Bern)
Lead sponsorStudiesRecruiting
Insel Gruppe AG, University Hospital Bern162129
University of Bern5033
University Hospital, Basel, Switzerland3121
Novartis Pharmaceuticals2210
AbbVie152
Hoffmann-La Roche154
Swiss Cancer Institute146
Merck Sharp & Dohme LLC123
Takeda119
Janssen Research & Development, LLC105
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.